Massachusetts General Hospital Cancer Center strives to be a leading provider of continuing medical education to oncology professionals. Our CME offerings focus on cutting edge technologies, treatments and advancements in cancer research and care.
October 26-27, 2015
The Liberty Hotel, Boston, MA
For more information and registration, click here.
Controversial Cases in Hematologic Malignancies and Hematology 2016
April 29-30, 2016
Colonnade Hotel • Boston, MA
Check back soon for more information.
- HER2-Positive Breast Cancer: After Trastuzumab, What’s Next?
- Investigational Treatments for Castration-Resistant Prostate Cancer
Participate in this innovative online activity to find a thorough review of the latest clinical trial data and treatment guidelines for castration-resistant prostate cancer, as well as guidance on the mechanism of action and efficacy of newly approved and late-stage investigational treatments.
U.S. News & World Report ranks the Mass General Cancer Center in the top 10 among U.S. hospitals.
Visit TargetedCancerCare.org for more information on the latest genomic research, cancer treatments and clinical trials.
Your gift of any amount will help us in our mission to advance knowledge and to rapidly translate discovery into exceptional cancer care. Learn more about making a gift, including tribute giving and other ways to get involved.